Academic literature on the topic 'Psychosis-like effects'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Psychosis-like effects.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Psychosis-like effects"

1

Euba, O., E. Zallo, M. Torreblanca, A. Arroita, N. Sánchez, and A. Barreiro. "Postraumatic Psychosis. Clinical Features." European Psychiatry 24, S1 (2009): 1. http://dx.doi.org/10.1016/s0924-9338(09)71146-0.

Full text
Abstract:
Aims:Traumatic brain injury (TBI) cause a wide range of after-effects, including psychiatric disorders. Psychosis although uncommon is a very serious consequences with important functional, therapeutical and legal implications.Methods:Our work is based on a systemic review of the articles published related to TBI and psychosis.Results and conclusions:Delirious psychosis are twice more common than schizophrenia-like psychosis (28% to 14%).Delusions and hallucinations are predominant over passive phenomena or negative symptoms.Evolution and chronicity of postraumatic psychosis depends on the sev
APA, Harvard, Vancouver, ISO, and other styles
2

van Amsterdam, Jan, Tibor Brunt, and Wim van den Brink. "The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects." Journal of Psychopharmacology 29, no. 3 (2015): 254–63. http://dx.doi.org/10.1177/0269881114565142.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Meyhöfer, Inga, Veena Kumari, Antje Hill, Nadine Petrovsky, and Ulrich Ettinger. "Sleep deprivation as an experimental model system for psychosis: Effects on smooth pursuit, prosaccades, and antisaccades." Journal of Psychopharmacology 31, no. 4 (2016): 418–33. http://dx.doi.org/10.1177/0269881116675511.

Full text
Abstract:
Current antipsychotic medications fail to satisfactorily reduce negative and cognitive symptoms and produce many unwanted side effects, necessitating the development of new compounds. Cross-species, experimental behavioural model systems can be valuable to inform the development of such drugs. The aim of the current study was to further test the hypothesis that controlled sleep deprivation is a safe and effective model system for psychosis when combined with oculomotor biomarkers of schizophrenia. Using a randomized counterbalanced within-subjects design, we investigated the effects of 1 night
APA, Harvard, Vancouver, ISO, and other styles
4

Barkus, E., and S. Lewis. "Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample." Psychological Medicine 38, no. 9 (2008): 1267–76. http://dx.doi.org/10.1017/s0033291707002619.

Full text
Abstract:
BackgroundThe relationship between cannabis use and psychosis is still a matter for debate. Accounting for the individual differences in subjective experiences to recreational cannabis use in the general population may hold some clues to the aetiological relationship between cannabis and psychotic symptoms. We hypothesized that schizotypy would account for the individual differences in subjective experiences after cannabis use but not in patterns of use.MethodIn a sample of 532 young people who had used cannabis at least once, we examined the relationship between the Cannabis Experiences Quest
APA, Harvard, Vancouver, ISO, and other styles
5

Taylor, Hannah E., Suzanne L. K. Stewart, Graham Dunn, Sophie Parker, David Fowler, and Anthony P. Morrison. "Core Schemas across the Continuum of Psychosis: A Comparison of Clinical and Non-Clinical Groups." Behavioural and Cognitive Psychotherapy 42, no. 6 (2013): 718–30. http://dx.doi.org/10.1017/s1352465813000593.

Full text
Abstract:
Background: Research suggests that core schemas are important in both the development and maintenance of psychosis. Aims: The aim of the study was to investigate and compare core schemas in four groups along the continuum of psychosis and examine the relationships between schemas and positive psychotic symptomatology. Method: A measure of core schemas was distributed to 20 individuals experiencing first-episode psychosis (FEP), 113 individuals with “at risk mental states” (ARMS), 28 participants forming a help-seeking clinical group (HSC), and 30 non-help-seeking individuals who endorse some p
APA, Harvard, Vancouver, ISO, and other styles
6

Solmaz, Volkan, Dursun Delibas, Sema Inanir, and Oytun Erbas. "Antipsychotic like effects of atorvastatin and melatonin in a psychosis model in rats." Journal of Mood Disorders 5, no. 3 (2015): 120. http://dx.doi.org/10.5455/jmood.20150714014531.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Shin, E. J., J. M. Kim, X. K. T. Nguyen, et al. "Effects of Gastrodia Elata Bl on Phencyclidine-Induced Schizophrenia-Like Psychosis in Mice." Current Neuropharmacology 9, no. 1 (2011): 247–50. http://dx.doi.org/10.2174/157015911795017263.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Bersani, Giuseppe, Pietropaolo Marino, Giuseppe Valeriani, et al. "Manic-Like Psychosis Associated with Elevated Trough Tacrolimus Blood Concentrations 17 Years after Kidney Transplant." Case Reports in Psychiatry 2013 (2013): 1–3. http://dx.doi.org/10.1155/2013/926395.

Full text
Abstract:
Several neurological side effects induced by tacrolimus are described in the scientific literature, ranging from mild neurological symptoms to delirium and psychosis. We report the case of a 46-year-old man with no prior psychiatric history who suddenly manifested manic-like psychosis associated with elevated trough tacrolimus blood concentrations 17 years after kidney transplant. The use of antipsychotics may improve the severity of symptoms; but in order to obtain a complete remission, the reduction in the dose of tacrolimus, or its replacement with alternative immunosuppressant therapies, i
APA, Harvard, Vancouver, ISO, and other styles
9

Barrantes-Vidal, Neus, Manel Monsonet, Anna Racioppi, and Thomas R. Kwapil. "M2. STRESS IS ASSOCIATED AND PREDICTS SCHIZOTYPIC AND PSYCHOTIC-LIKE EXPERIENCES IN THE FLOW OF DAILY LIFE IN NONCLINICAL AND INCIPIENT PSYCHOSIS INDIVIDUALS." Schizophrenia Bulletin 46, Supplement_1 (2020): S133. http://dx.doi.org/10.1093/schbul/sbaa030.314.

Full text
Abstract:
Abstract Background Daily-life stressors, specially of a social nature, seem to play an important role in the origin and expression of the continuum of psychosis vulnerability. This study examined whether social stress and social positive appraisals in daily-life were associated, respectively, with the occurrence and the decrease of momentary psychotic-like and paranoid experiences and symptoms across the psychosis continuum. Methods Both social stressors and positive appraisals, as well as psychotic and paranoid experiences, were collected by means of Experience Sampling Methodology over a we
APA, Harvard, Vancouver, ISO, and other styles
10

Tortelli, Andrea, Aurélie Nakamura, Federico Suprani, et al. "Subclinical psychosis in adult migrants and ethnic minorities: systematic review and meta-analysis." BJPsych Open 4, no. 6 (2018): 510–18. http://dx.doi.org/10.1192/bjo.2018.68.

Full text
Abstract:
BackgroundIt is well established that migration and ethnic minority status are risk factors for psychotic disorders. Recent studies have aimed to determine if they are also associated with subclinical psychosis (psychotic-like experiences and schizotypal traits).AimsWe aimed to determine to what extent migrant and ethnic minority groups are associated with higher risk of subclinical psychosis.MethodWe conducted a systematic review, using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement, and examined findings by ethnicity, migrant status, outcomes of subclinical
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Psychosis-like effects"

1

Lemprière, Sarah Alice. "Studying the synaptome : insights into ketamine action." Thesis, University of Edinburgh, 2018. http://hdl.handle.net/1842/33190.

Full text
Abstract:
Major depressive disorder (MDD) is a growing health problem. Current treatment options are not always effective and take several weeks of regular administration before an improvement can be seen in symptoms. Sub-anaesthetic doses of ketamine have been found to have antidepressant effects in previously treatment-resistant MDD after just one dose. However, ketamine also produces short term psychosis-like side effects which are undesirable for MDD patients. Ketamine is known to be an NMDA receptor antagonist, binding within the channel pore to block ion flow, however the molecular mechanism(s) un
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Psychosis-like effects"

1

Broussard, Beth, and Michael T. Compton. "Medicines Used to Treat Psychosis." In The First Episode of Psychosis, edited by Beth Broussard and Michael T. Compton. Oxford University Press, 2021. http://dx.doi.org/10.1093/med-psych/9780190920685.003.0007.

Full text
Abstract:
Many mental health professionals view medicines to be of utmost importance in the treatment of psychosis. The main types of medicines used to treat psychosis are antipsychotics, which are most effective for what are referred to as “positive symptoms” like hallucinations and delusions. Antipsychotics work by binding to dopamine (and, in some cases, serotonin) receptors in the brain, which affects the ways certain neurons communicate with one another. The length of time the medicine should be taken is based on the types of symptoms one experiences and how long the symptoms last. Sometimes antipsychotics cause side effects. It is important to discuss possible side effects from specific medicines with the psychiatrist, so that the person with psychosis and their families know which side effects to expect and how to handle them if they happen. Doctors usually try to find the lowest effective dose in order to minimize side effects, while still being effective in treating symptoms.
APA, Harvard, Vancouver, ISO, and other styles
2

Agüera-Ortiz, Luis. "Functional psychoses." In Oxford Textbook of Geriatric Medicine. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198701590.003.0137.

Full text
Abstract:
Psychotic symptoms are more common in older people than in any other age. The most frequent psychotic disorders in older people are juvenile-onset schizophrenia in ageing patients, psychosis in Alzheimer’s disease, and the late- and very late-onset schizophrenia-like psychosis. Drug treatment of all types of psychosis is essential and often achieves similar levels of efficacy than in younger adults. The treatment of choice for any psychotic condition is atypical antipsychotics. Rather than being based on specific diagnosis, the choice of drug must be highly personalized, depending on the efficacy for the particular patient, drug’s profile of adverse effects, medical comorbidities, and concomitant medications. Attention should be paid to the emergence of adverse effects that are in general more frequently found with conventional than with atypical antipsychotics. Clinical and psychological management includes the need to establish a therapeutic alliance with the patient and ensure adherence to treatment in the long term.
APA, Harvard, Vancouver, ISO, and other styles
3

Compton, Michael T., and Beth Broussard. "Medicines Used to Treat Psychosis." In The First Episode of Psychosis. Oxford University Press, 2010. http://dx.doi.org/10.1093/oso/9780195372496.003.0015.

Full text
Abstract:
Mental health professionals treat nearly all psychiatric illnesses using two types of treatments: medicines and psychosocial treatments. This is true for psychosis as well. We describe medicines used to treat psychosis in this chapter and psychosocial treatments for psychosis in Chapter 7. Medicines are a crucial part of the treatment plan for people who experience a first episode of psychosis. In fact, many mental health professionals view medicines to be the most important aspect of the treatment of psychosis. This is because psychosocial treatments are usually more effective when medicines help to adequately control symptoms. We discuss a number of medicines in this chapter. When a specific medicine is mentioned, two names are given. The first is the generic name and the second (in parentheses) is the trade name in the United States. For example, Tylenol is the trade name of the generic pain medicine called acetaminophen. Anyone taking medicine should be familiar with both the generic and trade names of the medicine, even though the generic names are sometimes more difficult to spell or pronounce. This chapter begins with an overview of the class of medicines used to treat psychosis, called antipsychotic medicines, or just “antipsychotics.” Before explaining antipsychotics in further detail, we set the stage by defining how antipsychotics work and some side effects and other serious problems called adverse events that may occur when taking antipsychotics. We then describe in more detail the two main types of medicines used to treat psychosis, the so-called “conventional” antipsychotics, and the “atypical” antipsychotics. Some mental health professionals refer to these as “first-generation” and “second-generation” antipsychotics, respectively. Then, we discuss the sometimes difficult task of finding the right medicine. We end by addressing two commonly asked questions about antipsychotic medicines: “Why is it important to take the medicine?” and “How long should the medicine be taken?” As mentioned earlier, the main types of medicines used to treat psychosis are the antipsychotics. These medicines are “antipsychotics” because they fight against (“anti-”) psychotic symptoms. As discussed in Chapter 1 (What Is Psychosis?) and Chapter 2 (What Are the Symptoms of Psychosis?), psychosis is a state of not being well-grounded in reality, due to symptoms like hallucinations or delusions.
APA, Harvard, Vancouver, ISO, and other styles
4

Winter, Jerrold. "Hallucinogens: Magic Mushrooms, Ayahuasca, Mescal Buttons, and Dr. Hofmann’s Problem Child." In Our Love Affair with Drugs. Oxford University Press, 2020. http://dx.doi.org/10.1093/oso/9780190051464.003.0011.

Full text
Abstract:
There are about 400,000 species of plants in this world. Only a small fraction, perhaps 100 in number, contain hallucinogenic chemicals. Nearly a century ago, Lewis Lewin, professor of pharmacology at the University of Berlin, in speaking of drugs he called phantasticants, said “The passionate desire which . . . leads man to flee from the monotony of daily life . . . has made him discover strange substances (which) have been integral to human evolution both societal and cultural for thousands of years.” An unusual problem presents itself to me in writing about these drugs: They straddle the worlds of science and mysticism. The Encyclopedia Britannica defines mysticism as the practice of religious ecstasies (religious experiences during alternate states of consciousness), together with whatever ideologies, ethics, rites, myths, legends, and magic may be related to them. Science I am comfortable with; mysticism not so much. Yet in our exploration of the agents found in this chapter, we will encounter many persons speaking of drug-induced mystical experiences. I have attempted to get around my unease by first providing the history and the pharmacology of these agents and then touching only lightly on mysticism, allowing readers to draw their own conclusions. What shall we call these chemicals? Hallucinogen, a substance that induces perception of objects with no reality, is the term most commonly encountered and the one that I have settled on for the title of this chapter. However, it comes with a caveat. Albert Hofmann, the discoverer of LSD, our prototypic hallucinogen, has pointed out that a true hallucination has the force of reality, but the effects of LSD only rarely include this feature. Two additional terms that we will find useful are psychotomimetic and psychedelic. We have already considered the former, an ability to mimic psychosis, in our discussion of amphetamine-induced paranoid psychosis in chapter 4 and the effects of phencyclidine in chapter 6. A psychedelic was defined in 1957 by Humphrey Osmond, inventor of the word, as a drug like LSD “which enriches the mind and enlarges the vision.”
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!